Bide Pharmatech Co., Ltd.

688073

CNE100005NV3

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
29.62 ^CNY	-4.85%		-0.37%	-46.63%

Jul. 09	Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	CI
Jul. 05	Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.	CI

Bide Pharmatech Co., Ltd.(SHSE:688073) added to Shanghai Stock Exchange Composite Index

October 12, 2023 at 12:00 am EDT

Bide Pharmatech Co., Ltd Added to Shanghai Stock Exchange Composite Index.

Latest news about Bide Pharmatech Co., Ltd.

Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	Jul. 08	CI
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.	Jul. 04	CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	Jul. 02	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	Apr. 01	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 02	CI
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	Jan. 03	CI
Bide Pharmatech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Dec. 08	CI
Bide Pharmatech Co., Ltd. authorizes a Buyback Plan.	Dec. 07	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Bide Pharmatech Co., Ltd.(SHSE:688073) added to Shanghai Stock Exchange Composite Index	23-10-12	CI
Certain A Shares of Bide Pharmatech Co., Ltd. are subject to a Lock-Up Agreement Ending on 11-OCT-2023.	23-10-10	CI
Bide Pharmatech's Actual Controllers to Buy Up to 10 Million Yuan More Shares	23-09-20	MT
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-04	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-13	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Bide Pharmatech Co., Ltd. has completed an IPO in the amount of CNY 1.428161 billion.	22-09-29	CI
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-09-14	CI

Chart Bide Pharmatech Co., Ltd.

Duration

Period

More charts

Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.

Sector

Biotechnology & Medical Research

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bide Pharmatech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

29.62 CNY

Average target price

41 CNY

Spread / Average Target

+38.42%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIDE PHARMATECH CO., LTD.	-46.63%	362M
MODERNA, INC.	+22.15%	46.56B
LONZA GROUP AG	+44.59%	41.67B
IQVIA HOLDINGS INC.	-2.37%	41.16B
ALNYLAM PHARMACEUTICALS, INC.	+33.84%	32.4B
ICON PUBLIC LIMITED COMPANY	+20.42%	28.18B
CELLTRION, INC.	-6.35%	28.1B
UNITED THERAPEUTICS CORPORATION	+48.83%	14.52B
MEDPACE HOLDINGS, INC.	+45.00%	13.74B
BIO-TECHNE CORPORATION	+0.06%	12.17B

Other Biotechnology & Medical Research